MENU
+Compare
COLL
Stock ticker: NASDAQ
AS OF
Oct 17 closing price
Price
$33.94
Change
+$0.73 (+2.20%)
Capitalization
1.07B

COLL Collegium Pharmaceutical Forecast, Technical & Fundamental Analysis

Collegium Pharmaceutical Inc is a specialty pharmaceutical company... Show more

COLL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for COLL with price predictions
Oct 17, 2025

COLL sees its Stochastic Oscillator climbs out of oversold territory

On October 16, 2025, the Stochastic Oscillator for COLL moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 56 instances where the indicator left the oversold zone. In of the 56 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where COLL's RSI Indicator exited the oversold zone, of 20 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for COLL just turned positive on October 17, 2025. Looking at past instances where COLL's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where COLL advanced for three days, in of 302 cases, the price rose further within the following month. The odds of a continued upward trend are .

COLL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 12, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on COLL as a result. In of 100 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

COLL moved below its 50-day moving average on September 23, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for COLL crossed bearishly below the 50-day moving average on September 26, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where COLL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for COLL entered a downward trend on October 17, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. COLL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.604) is normal, around the industry mean (17.681). P/E Ratio (32.019) is within average values for comparable stocks, (72.923). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.078). COLL has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (1.911) is also within normal values, averaging (46.505).

View a ticker or compare two or three
COLL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

COLL is expected to report earnings to rise 11.90% to $1.88 per share on November 06

Collegium Pharmaceutical COLL Stock Earnings Reports
Q3'25
Est.
$1.88
Q2'25
Beat
by $0.02
Q1'25
Missed
by $0.01
Q4'24
Beat
by $0.09
Q3'24
Beat
by $0.04
The last earnings report on August 07 showed earnings per share of $1.68, beating the estimate of $1.66. With 426.96K shares outstanding, the current market capitalization sits at 1.07B.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
100 Technology Center Drive
Phone
+1 781 713-3699
Employees
197
Web
https://www.collegiumpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
USLYX70.030.53
+0.76%
JHancock U.S. Global Leaders Growth R2
URNQX61.300.39
+0.64%
Victory Nasdaq 100 Index R6
BWLYX26.070.15
+0.58%
American Beacon Man Lg Cp Value Y
FNKIX18.910.10
+0.53%
Frank Value Instl
LGOQX26.81-0.11
-0.41%
Lord Abbett Growth Opportunities R2

COLL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, COLL has been loosely correlated with AMPH. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if COLL jumps, then AMPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COLL
1D Price
Change %
COLL100%
+2.20%
AMPH - COLL
41%
Loosely correlated
+2.41%
AMRX - COLL
39%
Loosely correlated
+0.51%
VTRS - COLL
38%
Loosely correlated
+0.69%
PAHC - COLL
34%
Loosely correlated
+2.98%
ZTS - COLL
34%
Loosely correlated
+0.56%
More

Groups containing COLL

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COLL
1D Price
Change %
COLL100%
+2.20%
Pharmaceuticals: Generic
industry (219 stocks)
39%
Loosely correlated
-0.27%